KRM Ayurveda Limited Crosses JPY 100+ Crore Revenue Milestone in FY26;H2 FY26 EBITDA Grows ~100% YoY and PAT Surges ~149%, with PAT MarginsNearly Doubling

New Delhi [India], May 5: KRM Ayurveda Limited (NSE: KRMAYURVED), one of India’s emerging integrated Ayurvedic healthcare platforms, announced its audited financial results for the year ended March 31, 2026.

Financial Performance Highlights

H2 FY26 vs H2 FY25

Particulars (₹ In Lakhs) H2 FY26 H2 FY25 YoY Growth
Revenue from operations 5,333.36 4,084.19 30.59%
EBITDA 1,787.10 884.09 102.14%
EBITDA Margin (%) 33.51% 21.65% 1,186.00 BPS
PAT 1,189.73 478.12 148.84%
PAT Margin (%) 22.31% 11.71% 1,060.00 BPS

FY26 vs FY25

Particulars (₹ In Lakhs) FY26 FY25 YoY Growth
Revenue from operations 10,169.07 7,655.27 32.84%
EBITDA 3,112.02 1,914.02 62.59%
EBITDA Margin (%) 30.60% 25.00% 560.02 BPS
PAT 2,012.00 1,121.41 79.42%
PAT Margin (%) 19.79% 14.65% 513.66 BPS

Key Business Highlights

  • Diversified Revenue Mix Driving Stability: KRM’s business model has evolved from being predominantly product-led in FY23, with services contributing just 6.59% of total sales, to a more balanced integrated healthcare model, with services contributing rising to 63.21% in FY26.
  • Expanding Integrated Healthcare Footprint: KRM now operates 6 hospitals, 8 clinics, 223+ bed capacity, with 40 physicians and 71 therapists across India.
  • IPO-Led Capital Strengthening: Following its ₹ 77 Crore NSE Emerge IPO, KRM strengthened liquidity & positioned itself for telemedicine, expansion, and medical tourism.

Industry Opportunity

  • India’s AYUSH market, valued at ~$43 billion in 2024, is projected to reach ~$200 billion by 2030, driven by preventive healthcare, digital health, wellness tourism, and government support.

Growth Drivers

  • Telemedicine scale-up
  • Tier II/III hospital expansion
  • International teleconsultation
  • Medical tourism
  • Certified Ayurveda training programs
  • Expanded product portfolio
  • Wider OTC distribution

Speaking on the Company’s Financial and Strategic Performance, Dr. Puneet Dhawan, Managing Director & Promoter, said:

“Our FY26 performance marks a transformational year for KRM Ayurveda as we crossed the %100 crore revenue milestone in FY26, while H2 FY26 EBITDA surged ~102% YoY and PAT grew ~149% YoY, reflecting the strength of our integrated healthcare model and disciplined execution. Our strategic focus on expanding hospitals, specialty care, and digital health is driving stronger margins, improving revenue quality, and deepening consumer trust. Backed by a strengthened post-IPO balance sheet, we are well-positioned to accelerate growth across India and global markets through digital healthcare, medical tourism, and innovation-led Ayurveda solutions.”

About KRM Ayurveda Limited

KRM Ayurveda Limited, established in 2019, is an integrated Ayurvedic healthcare company combining hospitals, clinics, telemedicine, product manufacturing, and D2C wellness solutions. Originally founded as a kidney-specialty hospital, it has evolved into a multispecialty platform offering holistic healthcare through authentic Ayurveda, modern practices, and scalable digital health solutions.

Website: www.akmiladvisors.com

Disclaimer: Certain statements in this document that are not historical facts are forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including government actions, local, political, or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

Related Posts

Batman x Samsonite: Iconic DC Super Hero, Reimagined Through the Lens of Modern Travel

Mumbai (Maharashtra) [India], November 16: Samsonite, the global leader in travel, luggage and mobility solutions, announces a licensing partnership with Warner Bros. Global Consumer Products to launch a collection inspired…

How ISAK Fragrances Is Carrying 170 Years of Lucknow’s Perfumery Legacy Into Indian Luxury

A sixth-generation perfumer is building a modern fragrance house on a family craft that began in the courts of nineteenth-century Lucknow. New Delhi [India], November 16: In the 1850s, a…

You Missed

Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam

  • By
  • November 16, 2026
Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam

8th International HKL Conference Begins at Gurdwara Bulandpuri Sahib; Flags of 116 Nations Hoisted to Promote Global Unity

  • By
  • November 16, 2026
8th International HKL Conference Begins at Gurdwara Bulandpuri Sahib; Flags of 116 Nations Hoisted to Promote Global Unity

Arif Patel: Shaping a New Generation of Real Estate Development in Dubai, UAE

  • By
  • November 16, 2026
Arif Patel: Shaping a New Generation of Real Estate Development in Dubai, UAE

World Diabetes Day: Understanding the Role of Nutrition in Blood Sugar Management and the Benefits of American Pistachios

  • By
  • November 16, 2026
World Diabetes Day: Understanding the Role of Nutrition in Blood Sugar Management and the Benefits of American Pistachios

Why Colonialism Still Matters: Museum of British Colonialism to Host Online Panel Discussion on 19 November

  • By
  • November 14, 2026
Why Colonialism Still Matters: Museum of British Colonialism to Host Online Panel Discussion on 19 November

Dr. R. K. Thukral and the Work of Bringing Neuropsychiatry Closer to Patients

  • By
  • November 14, 2026
Dr. R. K. Thukral and the Work of Bringing Neuropsychiatry Closer to Patients